Last reviewed · How we verify
Generic Azelaic Acid Foam
Azelaic acid reduces inflammation and bacterial growth in the skin by inhibiting mitochondrial enzymes and reducing reactive oxygen species production.
Azelaic acid reduces inflammation and bacterial growth in the skin by inhibiting mitochondrial enzymes and reducing reactive oxygen species production. Used for Acne vulgaris, Rosacea.
At a glance
| Generic name | Generic Azelaic Acid Foam |
|---|---|
| Sponsor | Actavis Inc. |
| Drug class | Topical antimicrobial and anti-inflammatory agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Azelaic acid exerts antimicrobial effects against Cutibacterium acnes and has anti-inflammatory properties that reduce erythema and papules. It also normalizes keratinization and reduces the production of inflammatory mediators, making it effective for treating acne and rosacea. The foam formulation enhances skin penetration and patient tolerability.
Approved indications
- Acne vulgaris
- Rosacea
Common side effects
- Pruritus
- Erythema
- Burning sensation
- Dryness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Generic Azelaic Acid Foam CI brief — competitive landscape report
- Generic Azelaic Acid Foam updates RSS · CI watch RSS
- Actavis Inc. portfolio CI